Lu Y - Search Results

1

Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion.

Wang W, Yang X, Dai J, Lu Y, Zhang J, Keller ET. Wang W, et al. Among authors: lu y. Oncogene. 2019 Jun;38(23):4540-4559. doi: 10.1038/s41388-019-0736-3. Epub 2019 Feb 12. Oncogene. 2019. PMID: 30755731 Free PMC article.

2

Separation of retinoid-induced epidermal and dermal thickening from skin irritation.

Varani J, Fligiel H, Zhang J, Aslam MN, Lu Y, Dehne LA, Keller ET. Varani J, et al. Among authors: lu y. Arch Dermatol Res. 2003 Nov;295(6):255-62. doi: 10.1007/s00403-003-0416-5. Epub 2003 Oct 16. Arch Dermatol Res. 2003. PMID: 14564458 Free PMC article.

3

Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone.

Zhang J, Dai J, Yao Z, Lu Y, Dougall W, Keller ET. Zhang J, et al. Among authors: lu y. Cancer Res. 2003 Nov 15;63(22):7883-90. Cancer Res. 2003. PMID: 14633717

4

In vivo visualization of aging-associated gene transcription: evidence for free radical theory of aging.

Zhang J, Dai J, Lu Y, Yao Z, O'Brien CA, Murtha JM, Qi W, Hall DE, Manolagas SC, Ershler WB, Keller ET. Zhang J, et al. Among authors: lu y. Exp Gerontol. 2004 Feb;39(2):239-47. doi: 10.1016/j.exger.2003.10.024. Exp Gerontol. 2004. PMID: 15036418

5

In vivo real-time imaging of TGF-beta-induced transcriptional activation of the RANK ligand gene promoter in intraosseous prostate cancer.

Zhang J, Lu Y, Dai J, Yao Z, Kitazawa R, Kitazawa S, Zhao X, Hall DE, Pienta KJ, Keller ET. Zhang J, et al. Among authors: lu y. Prostate. 2004 Jun 1;59(4):360-9. doi: 10.1002/pros.20019. Prostate. 2004. PMID: 15065084 Free article.

6

Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor.

Lu Y, Zhang J, Dai J, Dehne LA, Mizokami A, Yao Z, Keller ET. Lu Y, et al. Clin Exp Metastasis. 2004;21(5):399-408. doi: 10.1007/s10585-005-0056-6. Clin Exp Metastasis. 2004. PMID: 15672864 Free article.

7

Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.

Dai J, Keller J, Zhang J, Lu Y, Yao Z, Keller ET. Dai J, et al. Among authors: lu y. Cancer Res. 2005 Sep 15;65(18):8274-85. doi: 10.1158/0008-5472.CAN-05-1891. Cancer Res. 2005. PMID: 16166304

8

Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice.

Wallner L, Dai J, Escara-Wilke J, Zhang J, Yao Z, Lu Y, Trikha M, Nemeth JA, Zaki MH, Keller ET. Wallner L, et al. Among authors: lu y. Cancer Res. 2006 Mar 15;66(6):3087-95. doi: 10.1158/0008-5472.CAN-05-3447. Cancer Res. 2006. PMID: 16540658

9

Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion.

Lu Y, Cai Z, Galson DL, Xiao G, Liu Y, George DE, Melhem MF, Yao Z, Zhang J. Lu Y, et al. Prostate. 2006 Sep 1;66(12):1311-8. doi: 10.1002/pros.20464. Prostate. 2006. PMID: 16705739

10

CCR2 expression correlates with prostate cancer progression.

Lu Y, Cai Z, Xiao G, Liu Y, Keller ET, Yao Z, Zhang J. Lu Y, et al. J Cell Biochem. 2007 Jun 1;101(3):676-85. doi: 10.1002/jcb.21220. J Cell Biochem. 2007. PMID: 17216598 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48,126 results

Search Page

Filters